补充剂使用相关的心血管毒性
补充剂使用普遍且呈增加趋势,美国FDA监管主要限于上市后监测。多种补充剂可通过掺假、替代或固有毒性引起心血管毒性,机制包括中枢神经刺激、心脏离子通道中毒、心脏活性类固醇和内分泌调节。兴奋剂类(如麻黄、辛弗林、育亨宾)可致心动过速、高血压、高热、心肌梗死和心脏骤停;含乌头碱或木藜芦毒素的补充剂可致宽QRS波心律失常;小檗碱可延长QT间期并致多形性室性心动过速;黄夹竹桃来源的心脏活性类固醇和蟾蜍来源的类固醇可致严重毒性及死亡;甘草可致低钾血症并诱发尖端扭转型室速。结论认为补充剂相关的心血管毒性罕见但可危及生命。
要点
- 补充剂相关心血管毒性虽罕见,但可表现为致命性心律失常或心脏骤停,临床医生应保持警惕。
- 含麻黄、辛弗林、育亨宾等中枢兴奋作用的补充剂可致心动过速、高血压、高热、心肌梗死和心脏骤停。
- 含乌头碱或木藜芦毒素的补充剂可致宽QRS波心律失常;小檗碱可延长QT间期并致多形性室性心动过速。
- 黄夹竹桃来源的心脏活性类固醇与减肥产品「Nuez de la India」相关的严重毒性和死亡有关,疑为无意替代错误。
- 蟾蜍(Bufo spp.)来源的动物性心脏活性类固醇用作壮阳药时可致有临床意义的心脏毒性和死亡;甘草可致低钾血症并诱发尖端扭转型室速。
适用人群与场景
- 使用补充剂(包括兴奋剂类、含乌头碱或木藜芦毒素、小檗碱、黄夹竹桃、蟾蜍来源类固醇、甘草等)的人群
- 出现心血管毒性表现(如心动过速、高血压、高热、心肌梗死、心脏骤停、宽QRS波心律失常、QT间期延长、多形性室性心动过速、尖端扭转型室速)的患者
红旗征与不能漏的情况
- 使用补充剂后出现宽QRS波心律失常,提示含乌头碱或木藜芦毒素的补充剂中毒
- 使用小檗碱后出现QT间期延长和多形性室性心动过速
- 使用黄夹竹桃来源的减肥产品「Nuez de la India」后出现严重毒性或死亡,疑为无意替代错误
- 使用蟾蜍(Bufo spp.)来源的壮阳补充剂后出现有临床意义的心脏毒性和死亡
- 使用甘草后出现低钾血症和尖端扭转型室速
研究设计与关键结果
- 综述指出补充剂使用普遍且呈增加趋势,美国FDA监管主要限于上市后监测,引起安全性担忧。
- 补充剂相关心血管毒性可通过掺假、替代或补充剂固有毒性发生,机制包括中枢神经刺激、心脏离子通道中毒、心脏活性类固醇和内分泌调节。
- 兴奋剂类补充剂(如麻黄、辛弗林、育亨宾)的不良反应包括心动过速、高血压、高热、心肌梗死和心脏骤停。
- 含乌头碱或木藜芦毒素的补充剂可致宽QRS波心律失常;小檗碱抑制心肌细胞电压门控钾通道,导致QT间期延长和多形性室性心动过速。
- 黄夹竹桃来源的心脏活性类固醇与减肥产品「Nuez de la India」相关的严重毒性和死亡有关,疑为无意替代错误;蟾蜍来源的类固醇用作壮阳药也可致有临床意义的心脏毒性和死亡。
- 甘草补充剂可致低钾血症,并与尖端扭转型室速的发生相关。
- 结论认为补充剂相关有临床意义的心血管毒性罕见,但可通过多种机制发生,临床医生应保持警惕。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 临床医生应保持警惕,补充剂可能产生严重且有时危及生命的心血管中毒。
- 对使用补充剂后出现心血管毒性表现的患者,应考虑补充剂相关毒性的可能。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Supplement use is prevalent and appears to be increasing over time. In the United States, regulation by the Food and Drug Administration is limited largely to post-marketing surveillance, raising safety concerns. A variety of supplements have been associated with cardiovascular toxicity, which can occur via adulteration, substitution, or as a result of intrinsic toxicity of the supplement. Cardiovascular toxicity due to supplement use may arise via several different mechanisms, and has been reported with supplements that act as central nervous system stimulants, via poisoning of cardiac ion channels, as a result of cardioactive steroids, and by modulation of the endocrine system.
STIMULANTS: Supplements that act as central nervous system stimulants include those that act directly on adrenoreceptors or indirectly via the release of catecholamines, and include substances such as ephedra, synephrine, and yohimbine. Adverse effects vary depending on the agent and include tachycardia, hypertension, hyperthermia, myocardial infarction, and cardiac arrest.
ION CHANNEL POISONS: Poisoning of cardiac voltage-gated sodium channels has been reported with supplements that contain or are contaminated with aconitine or grayanotoxins and cause wide complex dysrhythmias. Inhibition of cardiac myocyte voltage-gated potassium channels is associated with berberine, leading to prolongation of the QT interval and polymorphic ventricular tachycardia.
CARDIOACTIVE STEROIDS: Cardioactive steroids derived from yellow oleander are implicated in serious toxicity and death associated with the weight loss product "Nuez de la India" in what appears to be an inadvertent substitution error. Animal-derived cardioactive steroids from the Bufo spp. of toad used as an aphrodisiac also cause clinically significant cardiac toxicity and death.
ENDOCRINE MODULATORS: Supplemental use of black licorice induces hypokalemia, and is associated with the development of torsade de pointes.
CONCLUSION: Clinically significant cardiovascular toxicity associated with supplement use is a fortunately rare phenomenon that can occur via multiple mechanisms. Clinicians should maintain awareness that supplements may produce serious and sometimes life-threatening cardiovascular poisoning.
参考来源
- Corcoran J. Cardiovascular toxicity associated with supplement use. Clin Toxicol (Phila). 2025. PMID: 40960841. doi:10.1080/15563650.2025.2550983
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。